Anti-COX IV Mouse Monoclonal Antibody (14Y2) joins the Abbkine Scientific family

Life science Research Company, Abbkine Scientific, officially releases the Anti-COX IV Mouse Monoclonal Antibody (14Y2).

Wuhan, China. 430074, 30th June 2017. Abbkine Scientific Co. Ltd has announced the release of its new Anti-COX IV Mouse Monoclonal Antibody (14Y2). COX IV, also called Cytochrome c Oxidase or Complex IV (EC 1.9.3.1), which is a large trans-membrane protein complex found in bacteria and the mitochondrion. It is located in the mitochondrial (or bacterial) membrane and is the last enzyme in the respiratory electron transport chain.

Otherwise known as the Cytochrome c oxidase polypeptide IV antibody, the COX IV antibody has a human, mouse and rat reactivity with a recombinant protein immunogen. The product is available in a liquid solution and affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.

The monoclonal antibody is hosted in the mouse, with Mouse IgG1 Isotype. The uniqueness of the antibody stems from its flexibility and durability, as it can be stored for about twelve months from the date of shipment. While it is advised that investigators determine the optimal working dilutions experimentally, the suggested starting dilutions are WB 1:1000-3000, reiterating its flexibility.

COX IV antibody is usually as a Mitochondrial Loading Control.

Find more details about Anti-COX IV Mouse Monoclonal Antibody (14Y2) at http://www.abbkine.com/product/anti-cox-iv-mouse-monoclonal-antibody-14y2-a01060/

About Abbkine Scientific

Abbkine Scientific Company Limited is a life science research company headquartered in California. Founded in 2012, the establishment has been able to spread its tentacles across the globe with increasing presence and acceptance from Asia Pacific thanks to its continuous efforts to make the world a better place.

Abbkine combines cutting edge technology with manufacturing engineering and cost advantage to provide innovative, high-quality assay kits and other research and scientific products enhance life science fundamental research and drug discovery amongst others.

Media Contact
Company Name: Abbkine Scientific
Contact Person: Media Relations
Email: Send Email
Phone: +86-27-59716789
Address:Bldg 1, Harbour of Technology Times, No.35, Optical Valley Ave
City: Wuhan
State: Hubei
Country: China
Website: http://www.abbkine.com/

Calendar

September 2017
M T W T F S S
« Aug    
 123
45678910
11121314151617
18192021222324
252627282930  

Latest Posts

Context Aware Computing Market is Anticipated to be worth more than USD 125 Billion by 2024 | Hexa Research

Read Full Article

Online Home Decor Market To Grow At A CAGR of 19.64% During The Forecasted Period 2017 To 2021: Hexa Reports

Read Full Article

Chlorinated Polyethylene Market Growth To Be Driven By Increasing Use In Chemical Industry Owing To Their Non-Corrosive Properties Till 2025: Grand View Research, Inc.

Read Full Article

BEHOLD THE POWER OF EGGS – Easterseals Colorado Teams with Corporate Donation Solutions to LAUNCH the MOST INCREDIBLE and UNIQUE FUNDRAISER in the USA

Read Full Article

Array Connector Market To Witness Enhanced Usage In Electronics and Computer Applications Till 2021 | Million Insights

Read Full Article

Array Connector Market To Witness Enhanced Usage In Electronics and Computer Applications Till 2021 | Million Insights

Read Full Article

Blood Serum Market To Witness Enhanced Usage In Advanced Diagnostics Test & Laboratory Experiments Till 2017 | Million Insights

Read Full Article

Satellite Payloads Market Is Expected To Exhibit Substantial Growth Owing To Increased Penetration Of Payloads In The Telecom Sector Till 2025: Grand View Research, Inc.

Read Full Article

Fiber Laser Market To Witness Enhanced Demand From Automobile and Electronics Applications Till 2022 | Million Insights

Read Full Article

Conductive Textiles Market Growth Is Likely To Boost By Technological Advancement And Rising Awareness Regarding Conductive Textiles Among Consumers Till 2025: Grand View Research, Inc.

Read Full Article